3.06
-2.28(-42.70%)
Currency In USD
Previous Close | 5.34 |
Open | 4.55 |
Day High | 4.55 |
Day Low | 2.9 |
52-Week High | 6.71 |
52-Week Low | 2.21 |
Volume | 11.2M |
Average Volume | 2.25M |
Market Cap | 388.17M |
PE | -306 |
EPS | -0.01 |
Moving Average 50 Days | 4.7 |
Moving Average 200 Days | 3.56 |
Change | -2.28 |
If you invested $1000 in Organogenesis Holdings Inc. (ORGO) since IPO date, it would be worth $313.85 as of May 09, 2025 at a share price of $3.06. Whereas If you bought $1000 worth of Organogenesis Holdings Inc. (ORGO) shares 5 years ago, it would be worth $809.52 as of May 09, 2025 at a share price of $3.06.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Organogenesis Supports CMS’ Local Coverage Determination Implementation Delay to Review Coverage Policies to Maintain Patient Access with High Quality Evidence of Effectiveness
GlobeNewswire Inc.
Apr 11, 2025 8:05 PM GMT
Organogenesis recommends CMS also implement an integrated coverage and payment policyCANTON, Mass., April 11, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, m
Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2025 Financial Results on May 8, 2025
GlobeNewswire Inc.
Apr 07, 2025 8:05 PM GMT
CANTON, Mass., April 07, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care an
Organogenesis Holdings Inc. to Report Fourth Quarter of Fiscal Year 2024 Financial Results on February 27, 2025
GlobeNewswire Inc.
Jan 27, 2025 12:30 PM GMT
CANTON, Mass., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and